孕前糖尿病主要先天性心脏病风险受糖化血红蛋白修饰
在加拿大阿尔伯塔省594773例出生中,孕前糖尿病(PDM)者主要先天性心脏病(mCHD)风险比为2.8,HbA1c>8.0%者校正风险比达8.5;研究提示应据此优化高危妊娠筛查转诊指征。
要点
- PDM孕妇子代mCHD发生率为6.4/1000,风险比2.8(95%CI 2.1-3.7)。
- HbA1c>8.0%的PDM者mCHD校正风险比为8.5(95%CI 5.0-14.4)。
- 研究数据有助于细化高危妊娠筛查的转诊指征。
核心结论
- PDM与mCHD风险比2.8相关,HbA1c>8.0%者风险比增至8.5,数据有助于细化高危妊娠筛查转诊指征。
研究设计与样本
- 基于加拿大阿尔伯塔省注册出生人群的队列分析,纳入594773例出生,其中mCHD 1412例。
- 通过阿尔伯塔围产健康计划登记数据链接糖尿病状态、孕<16周最大HbA1c及其他协变量。
- 采用对数二项模型计算校正风险比(aRR)。
主要发现
- PDM者mCHD发生率为48/7497(6.4/1000),风险比2.8(95%CI 2.1-3.7),P<0.0001。
- 全队列中母亲年龄增加aRR 1.03(95%CI 1.02-1.04),多胎aRR 1.37(95%CI 1.1-1.8),P=0.02。
- 母亲孕前体重>91 kg与mCHD风险无关。
- HbA1c≤6.1%、>6.1-8.0%、>8.0%对应的mCHD发生率分别为4.2/1000、6.8/1000、17.1/1000(PDM/妊娠期糖尿病出生)。
- PDM且HbA1c>8.0%者较无糖尿病者mCHD的aRR为8.5(95%CI 5.0-14.4),较HbA1c正常(≤6.1%)的PDM者aRR为5.5(95%CI 1.6-19.4)。
临床怎么用
- 作者认为这些数据应有助于细化高危妊娠筛查的转诊指征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The association between pregestational diabetes mellitus (PDM) and risk of congenital heart disease (CHD) is well recognized; however, the importance of glycemic control and other coexisting risk factors during pregnancy is less clear. We sought to determine the relative risk (RR) of major CHD (mCHD) among offspring from pregnancies complicated by PDM and the effect of first-trimester glycemic control on mCHD risk. METHODS: We determined the incidence of mCHD (requiring surgery within 1 year of birth or resulting in pregnancy termination or fetal demise) among registered births in Alberta, Canada. Linkage of diabetes status, maximum hemoglobin A1c (HbA1c) at < 16 weeks' gestation and other covariates was performed using data from the Alberta Perinatal Health Program registry. Risk of mCHD according to HbA1c was estimated as an adjusted RR (aRR), calculated using log-binomial modeling. RESULTS: Of 1412 cases of mCHD in 594 773 (2.37/1000) births in the study period, mCHD was present in 48/7497 with PDM (6.4/1000; RR, 2.8 (95% CI, 2.1-3.7); P < 0.0001). In the entire cohort, increased maternal age (aRR, 1.03 (95% CI, 1.02-1.04); P < 0.0001) and multiple gestation (aRR, 1.37 (95% CI, 1.1-1.8); P = 0.02) were also associated with mCHD risk, whereas maternal prepregnancy weight > 91 kg was not. The stratified risk for mCHD associated with HbA1c ≤ 6.1%, > 6.1-8.0% and > 8.0% was 4.2/1000, 6.8/1000 and 17.1/1000 PDM/gestational diabetes mellitus births, respectively; the aRR of mCHD associated with PDM and HbA1c > 8.0% was 8.5 (95% CI, 5.0-14.4) compared to those without diabetes and 5.5 (95% CI, 1.6-19.4) compared to PDM with normal HbA1c (≤ 6.1%). CONCLUSIONS: PDM is associated with a RR of 2.8 for mCHD, increasing to 8.5 in those with HbA1c > 8%. These data should facilitate refinement of referral indications for high-risk pregnancy screening. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- He R, Hornberger LK, Kaur A, et al. Risk of major congenital heart disease in pregestational maternal diabetes is modified by hemoglobin A1c. Ultrasound Obstet Gynecol. 2024. PMID: 37594210. doi:10.1002/uog.27456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。